theophylline has been researched along with Leukemia, Myeloid, Acute in 7 studies
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Excerpt | Relevance | Reference |
---|---|---|
"Acute myelogenous leukemia (AML) patients (24 consecutive patients, median age 71 years, 17 high-risk disease) were treated with all-trans retinoic acid, theophylline and valproic acid." | 7.75 | A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid. ( Bruserud, O; Corbascio, M; Gjertsen, BT; Lassalle, P; Ryningen, A; Stapnes, C, 2009) |
"Acute myelogenous leukemia (AML) patients (24 consecutive patients, median age 71 years, 17 high-risk disease) were treated with all-trans retinoic acid, theophylline and valproic acid." | 3.75 | A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid. ( Bruserud, O; Corbascio, M; Gjertsen, BT; Lassalle, P; Ryningen, A; Stapnes, C, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ryningen, A | 1 |
Stapnes, C | 1 |
Lassalle, P | 1 |
Corbascio, M | 1 |
Gjertsen, BT | 2 |
Bruserud, O | 2 |
Fredly, H | 1 |
Reikvam, H | 1 |
Peracchi, M | 1 |
Maiolo, AT | 1 |
Lombardi, L | 1 |
Catena, FB | 1 |
Polli, EE | 1 |
Kindzel'skiĭ, AL | 1 |
Gaĭdukova, SN | 1 |
Chaplinski, TJ | 2 |
Niedel, JE | 1 |
Bennett, TE | 1 |
Studzinski, GP | 1 |
Bhandal, AK | 1 |
Brelvi, ZS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Differentiation Induction Therapy for Acute Myelogenous Leukemia[NCT00175812] | Phase 1/Phase 2 | 24 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for theophylline and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarab | 2012 |
6 other studies available for theophylline and Leukemia, Myeloid, Acute
Article | Year |
---|---|
A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid.
Topics: Aged; Aged, 80 and over; Blood Cell Count; Drug Therapy, Combination; Female; Humans; Leukemia, Myel | 2009 |
Patterns of cyclic nucleotides in normal and leukaemic human leucocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Carbachol; Cyclic AMP; Cyclic GMP; Guanylate | 1980 |
[The diagnostic significance of a surface modification in the T-lymphocytes in acute leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Immunity, Cellular; Leukemia, | 1993 |
Cyclic AMP levels and cellular kinetics during maturation of human promyelocytic leukemia cells.
Topics: Bucladesine; Cell Cycle; Cell Division; Cell Line; Cyclic AMP; Dimethyl Sulfoxide; Dinoprostone; Hum | 1986 |
Study of differentiation of fresh myeloid leukemic cells by physiologic agents that induce a human promyelocytic leukemic line (HL-60) to differentiate.
Topics: Bucladesine; Cell Cycle; Cell Differentiation; Cell Line; Cells, Cultured; Cytarabine; Dinoprostone; | 1986 |
Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3.
Topics: Calcitriol; Cell Cycle; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Humans; L | 1985 |